Partnerships in Clinical Trials Sponsor Medpace recently released the white paper The Promise and Challenge of Adaptive Design: Oncology Trials which took an in-depth look at the benefits of adaptive clinical trials when used in oncology.
Clinical trials in oncology are particularly time consuming and many companies are looking for more effective ways to conduct their research. According to the white paper, only 20% of trials today are using adaptive clinical trials. But when designing an adaptive clinical trial from the beginning of a study, the flexibility in the protocol that is built into the trial allows for better adapting to the situation. The interim data points built in are established places throughout the trial that allow researchers to assess and change the protocol as needed.
What do you see as the major benefits of writing an adaptive clinical trial protocol?
The Partnerships in Clinical Trials Blog focuses on optimization intelligence, regulatory trends and globalization strategies for both sponsors and CROs. It is supported by a number of industry events.
Would you like to guest blog on our site? Or send us feedback? Send an email to firstname.lastname@example.org.